公司资料
Ironwood Pharmaceuticals 股价、新闻与催化剂
- 股票代码:
- IRWD
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
4.36 USD (+1.16%)
收盘价
最后更新: 2026年8月17日
540M USD
市值
股价为何变动
As of Aug 17, 2026, IRWD closed up 1.16% at $4.36. No new same-company headline was identified in the current news window.
公司概览
业务概览
Ironwood Pharmaceuticals is a gastrointestinal-focused company anchored by Linzess and a pipeline aimed at digestive health. Its story is centered on GI commercialization and pipeline extension.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Ironwood sits in specialty biopharma.
商业模式特征
The business combines commercial GI revenue with pipeline optionality, so investors track prescription trends, partnership economics, and product durability.
生物医药行业定位
Ironwood is a commercial specialty-pharma name whose valuation is tied to a limited number of digestive-health assets and their lifecycle.
未来催化剂
- Ironwood's catalysts are Linzess execution, GI commercial stability, and any pipeline or partnership update that clarifies the next growth vector. The company still needs the core franchise to stay durable.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。